主要遗传性阿尔茨海默症网络试验单元 (DIAN-TU):对试验的满意度和对未来临床试验的态度
1Jorge J Llibre Guerra, 4488 Forest Park 00328, T: 314.273-5439, St. Louis MO 63108, USA, jllibre-guerra@wustl.edu; Haiyan Liu, 4488 Forest Park 00328, T: 314.273-5819, St. Louis MO 63108, USA, haiyanliu@wustl.edu.
The journal of prevention of Alzheimer's disease
|May 6, 2024
概括
主要遗传性阿尔茨海默症网络试验单元 (DIAN-TU) 临床试验的参与者报告了高度的满意度和重新注册的意愿. 这些发现强调了参与者经验在未来临床试验设计中的重要性.
科学领域:
- 神经科学是一个神经科学.
- 临床研究 临床研究
- 阿尔茨海默病 阿尔茨海默病
背景情况:
- 临床试验的满意度对未来的研究设计至关重要,影响了坚持和未来的参与.
- 主要遗传性阿尔茨海默症网络试验单位 (DIAN-TU) 旨在改善参与者在阿尔茨海默症研究中的经验.
研究的目的:
- 检查参与者的满意度和对未来临床试验的态度在DIAN-TU.
- 确定影响参与者愿意参加后续研究的因素.
主要方法:
- 为DIAN-TU-001试验 (solanezumab/gantenerumab) 的参与者开发了一个匿名调查.
- 在24个地点邀请了194名参与者;58人完成了16个月 (2020-2021) 的调查.
- 回归分析探讨了试验经验,满意度和未来参与意图之间的联系.
主要成果:
- 报告了高满意度 (96.5%) 和愿意重新注册 (96.5%) 或推参与 (91.4%).
- 在人员和程序 (98.3%) 中,满意度很高,许多人报告了增强的医疗保健 (70.7%) 和自豪感 (84.5%).
- 人口统计学 (年龄,性别,教育) 不影响满意度;参与意愿与试验结果无关.
结论:
- DIAN-TU-001参与者表现出高度的动机和满意度,即使经过长期试验 (4-7年) 进行了广泛的评估.
- 降低参与者负担和障碍的功能可能会显著提高试验满意度.
- 研究结果支持以参与者为中心的方法在长期阿尔茨海默氏症临床试验中的积极影响.
关键词:
阿尔茨海默氏症 (AD) 是一种疾病.临床试验满意度 临床试验满意度主要遗传性阿尔茨海默症网络试验单位 (DIAN-TU)主要遗传性阿尔茨海默氏病 (DIAD) 是一种主要遗传性阿尔茨海默氏病.家庭卫生护理 (HHN)更多相关视频
相关概念视频
01:16Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
01:22Alzheimer's Disease: Treatment
181
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
181
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
02:20Longitudinal Research
12.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K